Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma.
Borsi E, Perrone G, Terragna C, Martello M, Dico AF, Solaini G, Baracca A, Sgarbi G, Pasquinelli G, Valente S, Zamagni E, Tacchetti P, Martinelli G, Cavo M.
Borsi E, et al. Among authors: valente s.
Oncotarget. 2014 Apr 15;5(7):1779-92. doi: 10.18632/oncotarget.1736.
Oncotarget. 2014.
PMID: 24732040
Free PMC article.